Nothing has changed from what they said in August, why would it.
A small amount of product has been produced recently to facilitate FDA required clinical studies and distribution trials during FY24.
And from the FY 24 outlook - The Company expects growth in other nutritional products and modest growth in ANZ and USA liquid milk. USA IMF sales are expected to be immaterial.
Media Updates, page-13787
-
- There are more pages in this discussion • 658 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.66 |
Change
-0.110(1.62%) |
Mkt cap ! $4.814B | |||
| Open | High | Low | Value | Volume |
| $6.70 | $6.70 | $6.62 | $6.694M | 1.005M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4715 | $6.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.66 | 1719 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |